Cancer BiologyBiomedicine & PharmacotherapyPeer-reviewed
siRNA-based Therapeutic Candidate Targeting PRDM2 for Inhibition of Lung Cancer Progression
Sanjay Kumar, Md. Zubbair Malik, Maya Chaturvedi…·Rupesh Chaturvedi
This study identifies ARIZ-047, an siRNA targeting PRDM2/RIZ2, as a therapeutic candidate that inhibits lung cancer progression by increasing RIZ1 expression and suppressing Wnt signaling.
3 citations